How can doctors determine if patients with systemic autoimmune joint disease following Lyme disease don’t have a persistent infection?
by Daniel J. Cameron, MD MPH The patients were prescribed anti-inflammatory therapies, primarily disease-modifying anti-rheumatic drugs (DMARDs). “These treatments included steroids (3%), NSAIDS (20%), disease-modifying anti-rheumatic drugs (DMARDs) (57%), most commonly methotrexate, but also TNF-inhibitors, or combinations of these agents,” reported Arvikar. [1] The authors assumed that the persistent Borrelia burgdorferi (Bb) infection had been […]